EXOME

all the information, none of the junk | biotech • healthcare • life sciences

BioBehavioral Nabs $10M

Xconomy Boston — 

BioBehavioral Diagnostics, the Westford, MA-based maker of a tool for diagnosing attention-deficit hyperactivity disorder, said today it has raised $10 million in a Series B financing. Sevin Rosen Funds and Tullis Dickerson led the round, according to the company. BioBehavioral plans to use the cash to expand its sales and marketing efforts, and do more clinical work for its Quotient ADHD System.